Protein & Cell
Abbreviated title (ISO 4) | Protein Cell |
---|---|
Discipline | Cell biology |
Language | English |
Edited by | Zihe Rao |
Publication details | |
Publisher | |
Publication history | 2010-present |
Frequency | Monthly |
Yes | |
2.851 | |
Indexing | |
ISSN |
1674-800X (print) 1674-8018 (web) |
LCCN | 2014254504 |
CODEN | PCREFB |
OCLC no. | 865290367 |
Links | |
Protein & Cell is a monthly peer-reviewed open access journal covering protein and cell biology. It was established in 2010 and is published by Springer Science+Business Media. The editor-in-chief is Zihe Rao (Nankai University). According to the Journal Citation Reports, the journal has a 2013 impact factor of 2.851.[1]
Genetic modification of human embryos controversy
Main article: CRISPR § Society and culture
In 2015, the journal sparked controversy when it published a paper reporting results of an attempt to alter the DNA of non-viable human embryos to correct a mutation that causes beta thalassemia, a lethal heritable disorder.[2][3] According to the paper's lead author, the paper had previously been rejected by both Nature and Science in part because of ethical concerns; the journals did not comment to reporters.[4]
References
- ↑ "Protein & Cell". 2013 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2014.
- ↑ Liang, Puping; Xu, Yanwen; Zhang, Xiya; Ding, Chenhui; Huang, Rui; Zhang, Zhen; Lv, Jie; Xie, Xiaowei; Chen, Yuxi; Li, Yujing; Sun, Ying; Bai, Yaofu; Songyang, Zhou; Ma, Wenbin; Zhou, Canquan; Huang, Junjiu (2015). "CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes". Protein & Cell 6: 363–72. doi:10.1007/s13238-015-0153-5. PMC 4417674. PMID 25894090.
- ↑ Kolata, Gina (23 April 2015). "Chinese Scientists Edit Genes of Human Embryos, Raising Concerns". The New York Times. Retrieved 24 April 2015.
- ↑ "Chinese scientists genetically modify human embryos". Nature. 22 April 2015.
External links
This article is issued from Wikipedia - version of the Saturday, December 26, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.